Guardant Health
GH
#1156
Rank
โ‚ฌ17.89 B
Marketcap
132,27ย โ‚ฌ
Share price
1.30%
Change (1 day)
60.28%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -โ‚ฌ0.4 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚ฌ1.18 Billion. In 2025 the company made an earning of -โ‚ฌ0.39 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.4 Billion2.85%
2025 -โ‚ฌ0.39 Billion-4.03%
2024 -โ‚ฌ0.4 Billion-9.12%
2023 -โ‚ฌ0.44 Billion-26.73%
2022 -โ‚ฌ0.6 Billion69.96%
2021 -โ‚ฌ0.36 Billion56.35%
2020 -โ‚ฌ0.23 Billion252.69%
2019 -โ‚ฌ63.54 Million-17.22%
2018 -โ‚ฌ76.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-โ‚ฌ61.67 Million-85.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚ฌ0.24 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA